77 related articles for article (PubMed ID: 36190686)
1. Vinpocetine improved neuropsychiatric and epileptic outcomes in a patient with a GABRA1 loss-of-function variant.
Gjerulfsen CE; Mieszczanek TS; Johannesen KM; Liao VWY; Chebib M; Nørby HAJ; Gardella E; Rubboli G; Ahring P; Møller RS
Ann Clin Transl Neurol; 2023 Aug; 10(8):1493-1498. PubMed ID: 37434477
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effect of nerolidol in traumatic brain injury associated behavioural comorbidities in rats.
Kaur A; Jaiswal G; Brar J; Kumar P
Toxicol Res (Camb); 2021 Jan; 10(1):40-50. PubMed ID: 33613971
[TBL] [Abstract][Full Text] [Related]
3.
Bhardwaj H; Vasudeva N; Sharma S
CNS Neurol Disord Drug Targets; 2024; 23(2):215-231. PubMed ID: 36809941
[TBL] [Abstract][Full Text] [Related]
4. Role of vinpocetine in ischemic stroke and poststroke outcomes: A critical review.
Al-Kuraishy HM; Al-Gareeb AI; Naji MT; Al-Mamorry F
Brain Circ; 2020; 6(1):1-10. PubMed ID: 32166194
[TBL] [Abstract][Full Text] [Related]
5. Contractile Responses of Murine Hearts Subjected to Different Modes of Motor Activity to Traumatic Brain Injury.
Vakhitov BI; Sergeevich Raginov I; Lvovich Zefirov T; Khatybovich Vakhitov I; Ildarovich Vakhitov L
Arch Razi Inst; 2021; 76(3):631-638. PubMed ID: 34824755
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacological activity of vinpocetine derivatives.
Dong ZC; Shi Y; Liu LJ; Feng TT; Zhou Y; Pan BW
RSC Adv; 2024 Mar; 14(12):7981-7991. PubMed ID: 38454939
[TBL] [Abstract][Full Text] [Related]
7. [Neuroprotection strategies: effect of vinpocetine in vitro oxidative stress models].
Pereira C; Agostinho P; Moreira PI; Duarte AI; Santos MS; Oliveira CR
Acta Med Port; 2003; 16(6):401-6. PubMed ID: 15631851
[TBL] [Abstract][Full Text] [Related]
8. Vinpocetine restores cognitive and motor functions in Traumatic brain injury challenged rats.
Bagri K; Deshmukh R
Inflammopharmacology; 2022 Dec; 30(6):2243-2259. PubMed ID: 36190686
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of vinpocetine against neurotoxicity of manganese in adult male rats.
Nadeem RI; Ahmed HI; El-Sayeh BM
Naunyn Schmiedebergs Arch Pharmacol; 2018 Jul; 391(7):729-742. PubMed ID: 29671021
[TBL] [Abstract][Full Text] [Related]
10. An update on vinpocetine: New discoveries and clinical implications.
Zhang YS; Li JD; Yan C
Eur J Pharmacol; 2018 Jan; 819():30-34. PubMed ID: 29183836
[TBL] [Abstract][Full Text] [Related]
11. Vinpocetine mitigates DMH-induce pre-neoplastic colon damage in rats through inhibition of pro-inflammatory cytokines.
Bharti Sonkar A; Kumar P; Kumar A; Kumar Gautam A; Verma A; Singh A; Kumar U; Kumar D; Mahata T; Bhattacharya B; Keshari AK; Maity B; Saha S
Int Immunopharmacol; 2023 Jun; 119():110236. PubMed ID: 37148772
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine -- a PDE1 inhibitor.
Deshmukh R; Sharma V; Mehan S; Sharma N; Bedi KL
Eur J Pharmacol; 2009 Oct; 620(1-3):49-56. PubMed ID: 19699735
[TBL] [Abstract][Full Text] [Related]
13. Combination of Vinpocetine and Dexamethasone Alleviates Cognitive Impairment in Nasopharyngeal Carcinoma Patients following Radiation Injury.
Zhang P; Cao Y; Chen S; Shao L
Pharmacology; 2021; 106(1-2):37-44. PubMed ID: 32294652
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the neuroprotective activities of vinpocetine, punicalagin, niacin and vitamin E against behavioural and motor disabilities of manganese-induced Parkinson's disease in Sprague Dawley rats.
Abu-Elfotuh K; Hamdan AME; Abbas AN; Alahmre ATS; Elewa MAF; Masoud RAE; Ali AA; Othman M; Kamal MM; Hassan FAM; Khalil MG; El-Sisi AM; Abdel Hady MMM; Abd-Elhaleim El Azazy MK; Awny MM; Wahid A
Biomed Pharmacother; 2022 Sep; 153():113330. PubMed ID: 35780621
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]